(DAE) Daetwyl I - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0030486770
DAE: Rubber Components, Sealing Solutions, Elastomer Parts, Medical Devices
Dätwyler Holding AG (SW:DAE) stands as a testament to precision engineering, crafting elastomer components that are integral to both healthcare and industrial applications. With a legacy spanning over a century, this Swiss-based company has carved a niche in providing mission-critical solutions, making it a compelling consideration for investors seeking stability and growth.
In the healthcare arena, Dätwyler excels in manufacturing rubber components for devices like prefilled syringes and injectable drug systems. Their components are not just parts; they are essential to the functionality and safety of medical equipment. This precision engineering creates a formidable competitive barrier, especially as the global demand for such components grows, driven by an aging population and the rise of injectable drugs.
Shifting focus to their industrial solutions, Dätwyler is a key player in the automotive sector, particularly in electric vehicles and combustion engines. Their sealing solutions are vital for the durability and performance of these systems. Beyond automotive, they serve diverse industries such as aerospace and machinery, showcasing a resilient business model that thrives on diversification and innovation in sealing technologies.
Financially, Dätwyler presents an intriguing profile with a market cap of 2390M CHF. While the current P/E ratio reflects strong growth expectations, the forward P/E hints at potential value as growth is factored in. The moderate P/S ratio underscores reasonable valuations relative to revenue, offering investors a balanced view of their investment proposition.
Additional Sources for DAE Stock
DAE Stock Overview
Market Cap in USD | 2,679m |
Sector | Industrials |
Industry | Industrial Distribution |
GiC Sub-Industry | Trading Companies & Distributors |
IPO / Inception |
DAE Stock Ratings
Growth 5y | -38.0% |
Fundamental | 53.4% |
Dividend | 43.9% |
Rel. Strength Industry | -38.3 |
Analysts | - |
Fair Price Momentum | 109.21 CHF |
Fair Price DCF | 260.05 CHF |
DAE Dividends
Dividend Yield 12m | 2.16% |
Yield on Cost 5y | 2.10% |
Annual Growth 5y | 1.30% |
Payout Consistency | 91.7% |
DAE Growth Ratios
Growth Correlation 3m | -11.7% |
Growth Correlation 12m | -87.9% |
Growth Correlation 5y | -41.9% |
CAGR 5y | -2.88% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | -1.34 |
Alpha | -42.71 |
Beta | 0.64 |
Volatility | 28.00% |
Current Volume | 11.3k |
Average Volume 20d | 11.3k |
As of February 23, 2025, the stock is trading at CHF 131.60 with a total of 11,313 shares traded.
Over the past week, the price has changed by -3.52%, over one month by -2.66%, over three months by +0.00% and over the past year by -28.56%.
Partly, yes. Based on ValueRay Fundamental Analyses, Daetwyl I (SW:DAE) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.41 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DAE as of February 2025 is 109.21. This means that DAE is currently overvalued and has a potential downside of -17.01%.
Daetwyl I has no consensus analysts rating.
According to ValueRays Forecast Model, DAE Daetwyl I will be worth about 126.9 in February 2026. The stock is currently trading at 131.60. This means that the stock has a potential downside of -3.56%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 166 | 26.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 126.9 | -3.6% |